Wednesday, May 27, 2020 9:35:31 AM
4:17 PM ET 5/26/20 | BusinessWire
- Real-time glucose data and alerts of Eversense CGM users can now be remotely monitored by friends and family on Android or iOS operating system
GERMANTOWN, Md.--(BUSINESS WIRE)--May 26, 2020--
Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced the launch of Eversense(R) NOW Remote Monitoring App for Android Operating System.
"Now more than ever, the world relies upon remote methods of contact and support," said Tim Goodnow, PhD, President and CEO of Senseonics. "With the Eversense NOW app, Eversense CGM users can enjoy the added peace of mind that comes with knowing friends and family can remotely view real-time glucose data, see trend graphs, and receive real-time glucose alerts. With the launch of the Android platform, it joins our previously available Eversense NOW iOS platform to provide added support and convenience for our users during these unprecedented times."
Eversense users, and their friends and family can update to the latest version of the Eversense CGM app and the Eversense NOW remote monitoring app now available on the Apple(R) App Store and Google Play(TM).
The Eversense CGM System consists of a fluorescence-based sensor, a smart transmitter worn over the sensor to facilitate data communication, and a mobile app for displaying glucose values, trends and alerts. In addition to featuring the first long-term and first implantable CGM sensor, the system is also first to feature a smart transmitter that provides wearers with discreet on-body vibratory alerts for high and low glucose and can be removed, recharged and re-attached to the skin without discarding the sensor. The sensor is inserted subcutaneously in the upper arm by a health care provider via a brief in-office procedure and lasts up to 90 days.
About Eversense
The Eversense(R) Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels in persons age 18 and older with diabetes for up to 90 days. It is intended to replace fingerstick blood glucose monitoring. The sensor insertion and removal is performed by a health care provider. The Eversense CGM System is a prescription device; patients should talk to their health care provider to learn more. For important safety information, see global.eversensediabetes.com/safety-info.
About Senseonics
Senseonics Holdings, Inc. is a medical technology company focused on the design, development and commercialization of transformational glucose monitoring products designed to help people with diabetes confidently live their lives with ease. Senseonics' CGM Systems, Eversense(R) and Eversense(R) XL, include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200526005822/en/
CONTACT: Senseonics Investor Contact
Lynn Lewis or Philip Taylor
415-937-5406
investors@senseonics.com
Senseonics Media Contact:
Mirasol Panlilio
301-556-1631
Mirasol.panlilio@senseonics.com
SOURCE: Senseonics Holdings, Inc.
Copyright Business Wire 2020
> Dow Jones Newswires
May 26, 2020 16:17 ET (20:17 GMT)
Recent SENS News
- FDA Clearance Announcement Sends Small Cap Soaring • AllPennyStocks.com • 09/17/2024 03:50:00 PM
- Eversense 365 Receives FDA Clearance: The World’s First One Year CGM • GlobeNewswire Inc. • 09/17/2024 11:00:00 AM
- Eversense 365 Receives FDA Clearance: The World’s First One Year CGM • Business Wire • 09/17/2024 11:00:00 AM
- Senseonics Holdings, Inc. to Participate in the Upcoming H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 09/06/2024 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:21:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:10:28 PM
- Senseonics Holdings, Inc. Reports Second Quarter 2024 Financial Results • Business Wire • 08/08/2024 08:05:00 PM
- Senseonics Holdings, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for August 8, 2024 at 4:30 P.M. Eastern Time • Business Wire • 07/25/2024 08:05:00 PM
- Senseonics Holdings, Inc. Provides Business Update and Full Year 2024 Financial Outlook • Business Wire • 06/21/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 08:15:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 08:15:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 08:15:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 08:15:24 PM
- Senseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Association’s 84th Scientific Sessions • Business Wire • 06/13/2024 08:05:00 PM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/31/2024 08:39:39 PM
- Senseonics Holdings, Inc. to Participate in the Sidoti Small Cap Conference • Business Wire • 05/29/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 08:47:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 08:46:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 08:45:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 08:45:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 08:45:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 08:45:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 08:45:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 08:45:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 08:45:25 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM